Discovering Europe's Undiscovered Gems In May 2025
The European market has shown resilience with the pan-European STOXX Europe 600 Index rising by 3.44% as easing tariff concerns have bolstered investor confidence, while economic growth in the eurozone accelerated to 0.4% in the first quarter. Amid this positive backdrop, identifying promising small-cap stocks that can capitalize on these favorable conditions requires a keen eye for companies with strong fundamentals and potential for growth in an evolving economic landscape.
Top 10 Undiscovered Gems With Strong Fundamentals In Europe
Name
Debt To Equity
Revenue Growth
Earnings Growth
Health Rating
AB Traction
NA
3.81%
3.66%
★★★★★★
Caisse Régionale de Crédit Agricole Mutuel Brie Picardie Société coopérative
26.90%
4.14%
7.22%
★★★★★★
ABG Sundal Collier Holding
8.55%
-4.14%
-12.38%
★★★★★☆
Decora
20.76%
12.61%
12.54%
★★★★★☆
Caisse Regionale de Credit Agricole Mutuel Toulouse 31
19.46%
0.47%
7.14%
★★★★★☆
Viohalco
91.31%
12.25%
17.37%
★★★★☆☆
Practic
5.21%
4.49%
7.23%
★★★★☆☆
Inversiones Doalca SOCIMI
15.57%
6.53%
7.16%
★★★★☆☆
Grenobloise d'Electronique et d'Automatismes Société Anonyme
0.01%
5.17%
-13.11%
★★★★☆☆
MCH Group
124.09%
12.40%
43.58%
★★★★☆☆
Click here to see the full list of 328 stocks from our European Undiscovered Gems With Strong Fundamentals screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Value Rating: ★★★★★☆
Overview: Next Geosolutions Europe SpA offers geoscience and engineering services for the energy, infrastructure, and utilities sectors with a market capitalization of €386.88 million.
Operations: Next Geosolutions Europe SpA generates revenue primarily from its engineering services, totaling €304.99 million.
Next Geosolutions Europe, a promising name in the sector, has demonstrated significant growth with earnings surging 47.8% over the past year, outpacing the Construction industry's 18%. The company reported sales of €301.8 million for 2024, a substantial increase from €79.9 million in the previous year. Despite net profit margins dipping to 14.1% from last year's 35.8%, NXT remains attractive as it trades at nearly 57.8% below its estimated fair value and maintains strong interest coverage with EBIT covering interest payments by over 92 times, highlighting robust financial health and potential for future expansion.
BIT:NXT Earnings and Revenue Growth as at May 2025
Simply Wall St Value Rating: ★★★★★★
Overview: Pexip Holding ASA is a video technology company that offers an end-to-end video conferencing platform and digital infrastructure across various regions including the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with a market cap of NOK4.79 billion.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
an hour ago
- New York Times
Trump as Channel-Changer in Chief
The newly elected chancellor of Germany had patiently waited on Thursday as President Trump took questions from reporters about a range of topics, including an explosive war of words with Elon Musk that was just erupting online. Finally, the chancellor, Friedrich Merz, saw a chance to get back to his own top priority: Ukraine. 'We are on the side of Ukraine,' Merz said flatly, adding, 'We are trying to get them stronger and stronger just to make Putin stop this war.' And he exalted Trump as 'the key person in the world' to help end the conflict. Merz had Trump — briefly. For a few seconds, Trump murmured in agreement. He described having seen gruesome battlefield footage and acknowledged that the war was 'a terrible, terrible thing.' But then, like a sports fan who had accidentally found himself watching PBS, he changed the channel. 'Did I hear the word autopen?' Trump said, returning to a topic he had already expounded upon: former President Joe Biden's use of an autopen to sign legislation. 'I think it's the biggest scandal maybe in the last 100 years in this country,' he said. The moment crystallized Trump's approach in recent weeks to some of the more challenging issues facing the administration and the world. As wars and conflicts overseas become only more intractable, Trump has frequently sought to pivot to the red-meat domestic topics that he knows will fire up his base. Want all of The Times? Subscribe.
Yahoo
2 hours ago
- Yahoo
Trump reluctant to confront China over support for Russia's war against Ukraine, Bloomberg reports
U.S. President Donald Trump is pulling back from pressuring China over its support for Russia's war effort, instead prioritizing other aspects of the U.S.-China relationship, U.S. and European officials familiar with internal discussions told Bloomberg. These officials, speaking anonymously, said that the administration has lowered the issue of Russia's war against Ukraine on its list of foreign policy priorities and is focusing on bilateral issues with Beijing, though they noted Trump could still shift course. The change in approach marks a departure from the long-held stance of the U.S. and its G7 partners, who have consistently called out China as a key enabler of Russia's war in Ukraine. In March, G7 foreign ministers condemned Beijing's support for Moscow and urged it to use its influence over Russian President Vladimir Putin to help end the war. However, Trump said that "nothing was discussed concerning Russia/Ukraine" during his recent call with Chinese President Xi Jinping. Officials suggest this pivot reflects Trump's desire to break with the foreign policy priorities of former President Joe Biden, who viewed relations with other governments largely through the lens of Russia's invasion of Ukraine. Instead, Trump's team is prioritizing issues like tariffs, technology restrictions, and rare earths. One official noted that Trump is reluctant to directly criticize China's role in aiding Russia while he continues talks with Putin aimed at brokering a ceasefire. At the same time, Trump ally Senator Lindsey Graham is pushing for new sanctions against Russia, including measures targeting Chinese and Indian purchases of discounted Russian oil. Graham's bill has gained over 80 co-sponsors in the Senate, signaling strong bipartisan support. U.S. officials have also expressed frustration at European countries that continue buying Russian energy while criticizing Beijing's exports to Moscow—exports that include dual-use components and sanctioned technologies used in weapons production. Despite Trump's current stance, the European Union has maintained public pressure on China, both through diplomatic channels and public statements. EU foreign policy chief Kaja Kallas recently accused Beijing of fueling Russia's war through dual-use exports. Moscow has continued to receive critical components from China, including drone parts, even as Beijing has restricted similar exports to Ukraine and the West. While the Biden administration and EU have sanctioned several Chinese firms involved in aiding Russia's military production, Trump has yet to impose any new penalties. Read also: 'Find and destroy' – how Ukraine's own Peaky Blinders mastered the art of bomber drones We've been working hard to bring you independent, locally-sourced news from Ukraine. Consider supporting the Kyiv Independent.
Yahoo
3 hours ago
- Yahoo
EU plan would limit Chinese device makers in Europe
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. European Union member states this week voted to support a plan to adopt measures that would restrict Chinese medical device makers' access to the EU market. The member states took the action, under the EU's International Procurement Instrument, after concluding an investigation in January that looked at China's practices in the public procurement market for medical devices. The investigation found that government practices unfairly encouraged Chinese hospitals to choose domestic manufacturers' products. 'The Commission has identified measures and practices in the Chinese procurement market that lead to discrimination against EU operators and EU-made supplies,' Olof Gill, commission spokesperson, said Thursday in an emailed statement. 'This discrimination also harms both the Chinese healthcare infrastructure, which is deprived of quality equipment, and EU businesses, with a high cost in terms of jobs and economic activity in the EU.' The commission has discussed its concerns with Chinese authorities. However, a satisfactory solution has not been proposed, and the EU had no other option than to tackle the issue through an IPI investigation, Gill wrote. The commission said it could not disclose the content of the draft IPI measure or next steps in the process. Chinese manufacturers would be prohibited from bidding on public procurement contracts worth more than 5 million euros for five years. In addition, no more than 50% of a contract's value may be subcontracted to Chinese entities or include Chinese-origin medical devices, MedTech Europe said in a statement. The trade group said it would provide further updates once the IPI measures are published in the EU's official journal. The EU investigation into China's medical device procurement practices was the first use of the IPI, which was introduced in 2022. Getting fair access to Chinese markets became more challenging for medical device companies after the country launched a program calling for domestically produced medical equipment to achieve 50% market penetration in county-level hospitals by 2020 and 70% by 2025, according to a statement from the European Chamber, which represents European businesses in China. European and Chinese leaders will meet in July at a summit in Beijing. Recommended Reading EU mulls retaliation after showing China's bias against foreign device firms Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
